arrow
C

Christoph Kleinschnitz

University Medicine Essen
H指数:80
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Machine learning models for adverse drug reaction prediction. A systematic review and three-level multilevel meta-analysis

机器学习模型用于药物不良反应预测:系统综述和三级多层元分析

2026-09-150
OA
Practical Guidance on Initiating and Switching Targeted Immunotherapies in Generalised Myasthenia Gravis: A German–Austrian Expert Opinion Paper

关于在全身性重症肌无力中启动和转换靶向免疫疗法:一项德奥专家意见论文

2026-09-100
OAAI
The kallikrein-kinin system modulates CD4+ T cell function and contributes to T cell migration into the brain after stroke

激肽释放酶-激肽系统调控CD4+ T细胞功能,并促进卒中后T细胞向大脑迁移

2026-09-050
OAAI
Corrigendum to “Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment” [Biomed. Pharmacother. 183 (2025) 117829]

更正:题为“揭示可溶性鸟苷酸环化酶激活与氧化还原信号在卒中病理生理和治疗中的相互作用”的文章 [Biomed. Pharmacother. 183 (2025) 117829]

2026-09-020
OA
Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation

松果体区乳头状肿瘤中的年龄相关表观基因组异质性:一项多中心YoungNOA研究

2026-08-280
OA
Mental health and suicidality in glioblastoma patients in germany – a multicenter cross-sectional observational study protocol (SHINE-GLIO Study)

德国胶质母细胞瘤患者的心理健康和自杀行为——一项多中心横断面观察性研究方案(SHINE-GLIO研究)

2026-08-060
OAAI
Safety and feasibility of tumor treating fields initiated before and during radiotherapy for newly diagnosed glioblastoma: results from the Arm A feasibility cohort of a phase I/II trial (PriCoTTF)

新诊断胶质母细胞瘤中肿瘤治疗电场在放疗前和放疗期间的安全性与可行性:PriCoTTF I/II期试验中Arm A可行性队列的结果

2026-07-270
OAAI
COVID-19 and Influenza Booster Vaccination Elicits Robust Antibody Responses in Patients with Primary Brain Tumors Comparable to Healthy Adults

新型冠状病毒肺炎和流感加强疫苗接种可在与健康成年人相当的原发性脑肿瘤患者中引起强大的抗体反应

Cancers
IF4.4
2026-02-030
OAAI
Choosing the optimal mouse model for the study of late-onset spinal muscular atrophy: Why the 4-copy SMN2 model offers ideal translational relevance

选择用于研究迟发性脊髓性肌萎缩症的最佳小鼠模型: 为什么4份 <i>SMN2</i> 模型提供了理想的翻译相关性

2026-01-160
PRE
End-of-life challenges in neuro-oncological patient care: A survey from the Junge Neuroonkologische Arbeitsgemeinschaft

神经肿瘤患者临终关怀中的挑战:德国青年神经肿瘤学工作组调查

2026-01-010
PRE
Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapy

氯达拉滨片在多发性硬化治疗中实现无治疗缓解是否是一个现实的目标?关于氯达拉滨片作用机制及免疫重建的临床意义的新见解

2025-11-270
OAAI
CT-guided Lumbar Puncture for Intrathecal Nusinersen Injection in Patients with Spinal Muscular Atrophy: Technical Effectiveness, Safety, and Radiation Dose

CT引导下腰椎穿刺用于脊髓性肌萎缩症患者鞘内注射Nusinersen:技术有效性、安全性与辐射剂量

2025-11-010
OAAI
NON-INFERIOR IMMUNE RESPONSES UPON COVID-19 BOOSTER AND SEASONAL INFLUENZA VACCINATION IN PRIMARY BRAIN TUMOR PATIENTS

接受新冠疫苗加强针和季节性流感疫苗接种的原发性脑肿瘤患者的非劣效免疫反应

2025-11-010
OAAI
THE MOLECULAR LANDSCAPE AND ITS PROGNOSTIC IMPLICATIONS IN ADULT PAPILLARY TUMORS OF THE PINEAL REGION - A MULTICENTER YOUNGNOA INVESTIGATION

松果体区成人乳头状肿瘤的分子景观及其预后意义——一项多中心YoungNoa研究

2025-11-010
PRE
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?

新诊断胶质母细胞瘤患者中骨髓毒性的分布及预后意义:是否应更积极治疗?

2025-11-010
OAAI